In this episode of Psych Matters, A/Prof Suresh Muthukumaraswamy and Dr Chiranth Bhagavan discuss Suresh's talk 'A sceptical look at the use of psychedelic drugs in medicine'. While there is significant interest in the use of psychedelics as medicines in psychiatry the evidence base has a number of limitations and these are delved into in this discussion.
Interested listeners can read in more detail:
A/Prof Suresh Muthukumaraswamy is an Associate Professor in The School of Pharmacy at The University of Auckland. His research Suresh’s main research interests are in understanding how therapies alter brain function and behaviour and in testing methodologies to measure these changes in both healthy individuals and patient groups – particularly in depressed patients. He has investigated over 20 different CNS drugs and began research into psychedelics in 2011.
Dr Chiranth Bhagavan is a senior psychiatry registrar and consultation-liaison advanced trainee currently in a dual clinical and academic role in Auckland, New Zealand.
If you have a topic suggestion or would like to participate in a future episode of Psych Matters, we’d love to hear from you.
Please contact us by email at: firstname.lastname@example.org
This podcast is provided to you for information purposes only and to provide a broad public understanding of various mental health topics. The podcast may represent the views of the author and not necessarily the views of The Royal Australian and New Zealand College of Psychiatrists ('RANZCP'). The podcast is not to be relied upon as medical advice, or as a substitute for medical advice, does not establish a doctor-patient relationship and should not be a substitute for individual clinical judgement. By accessing The RANZCP's podcasts you also agree to the full terms and conditions of the RANZCP's Website. Expert mental health information and finding a psychiatrist in Australia or New Zealand is available on the RANZCP’s Your Health In Mind Website.